↓ Skip to main content

Ideal Antiplatelet Therapy for Coronary Artery Disease

Overview of attention for article published in American journal of therapeutics (Print), July 2013
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age and source (61st percentile)

Mentioned by

twitter
1 X user
facebook
1 Facebook page

Citations

dimensions_citation
5 Dimensions

Readers on

mendeley
15 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Ideal Antiplatelet Therapy for Coronary Artery Disease
Published in
American journal of therapeutics (Print), July 2013
DOI 10.1097/mjt.0b013e31820b8668
Pubmed ID
Authors

Suraj Chandrasekar, Rohit Loomba, Parinda Shah, Rohit Arora

Abstract

With the increasing prevalence of coronary artery disease, antiplatelet therapy after percutaneous coronary intervention is becoming more important. As such realm is still very dynamic, it is important for clinicians to understand the evolution of antiplatelet therapies and current issues that are yet to be settled in the search for an ideal antiplatelet agent. Electronic searches were done using databases such as PubMed and Cochrane Library with appropriate keywords. Randomized controlled trials and retrospective studies found were then assessed for quality, and their references used to find additional studies. The field of study regarding the antiplatelet therapy is still an area in which much has yet to be found. Although clopidogrel and aspirin are cornerstones of therapy currently, other agents such as ticagrelor offer potential alternatives. This review presents an overview of current antiplatelet therapies and their relative risks and benefits.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 15 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 15 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 3 20%
Student > Doctoral Student 2 13%
Researcher 2 13%
Student > Master 2 13%
Student > Bachelor 1 7%
Other 2 13%
Unknown 3 20%
Readers by discipline Count As %
Medicine and Dentistry 4 27%
Biochemistry, Genetics and Molecular Biology 2 13%
Agricultural and Biological Sciences 2 13%
Nursing and Health Professions 1 7%
Social Sciences 1 7%
Other 1 7%
Unknown 4 27%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 February 2013.
All research outputs
#19,945,185
of 25,374,917 outputs
Outputs from American journal of therapeutics (Print)
#707
of 1,367 outputs
Outputs of similar age
#150,693
of 206,712 outputs
Outputs of similar age from American journal of therapeutics (Print)
#3
of 13 outputs
Altmetric has tracked 25,374,917 research outputs across all sources so far. This one is in the 18th percentile – i.e., 18% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,367 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 41.5. This one is in the 39th percentile – i.e., 39% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 206,712 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 23rd percentile – i.e., 23% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 13 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 61% of its contemporaries.